ATE378421T1 - Glycosyltransferase inhibitoren - Google Patents

Glycosyltransferase inhibitoren

Info

Publication number
ATE378421T1
ATE378421T1 AT00936281T AT00936281T ATE378421T1 AT E378421 T1 ATE378421 T1 AT E378421T1 AT 00936281 T AT00936281 T AT 00936281T AT 00936281 T AT00936281 T AT 00936281T AT E378421 T1 ATE378421 T1 AT E378421T1
Authority
AT
Austria
Prior art keywords
inhibitors
glycosyltransferase
glycosyltransferase inhibitors
glyscosyltranferase
glycosyltransferases
Prior art date
Application number
AT00936281T
Other languages
English (en)
Inventor
Shawn Defrees
Original Assignee
Abaron Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abaron Biosciences Inc filed Critical Abaron Biosciences Inc
Application granted granted Critical
Publication of ATE378421T1 publication Critical patent/ATE378421T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00936281T 1999-05-24 2000-05-24 Glycosyltransferase inhibitoren ATE378421T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13615099P 1999-05-24 1999-05-24
US57712099A 1999-05-24 1999-05-24

Publications (1)

Publication Number Publication Date
ATE378421T1 true ATE378421T1 (de) 2007-11-15

Family

ID=26834046

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00936281T ATE378421T1 (de) 1999-05-24 2000-05-24 Glycosyltransferase inhibitoren

Country Status (4)

Country Link
EP (1) EP1185269B1 (de)
AT (1) ATE378421T1 (de)
DE (1) DE60037113T2 (de)
WO (1) WO2001068095A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0421368D0 (en) * 2004-09-25 2004-10-27 Univ York Glycosyltransferase assay
EP2720044A1 (de) 2012-10-15 2014-04-16 National University of Ireland, Galway Sialyltransferase ST3GAL6 als Marker für multiples Myelom
CN105579578A (zh) 2013-08-12 2016-05-11 贝纳罗亚研究院·弗吉尼亚梅森 用于免疫调节的4-甲基伞形酮治疗
CN111437283A (zh) * 2020-03-09 2020-07-24 吉林大学 β1,4-半乳糖基转移酶抑制剂在制备治疗癌症的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668505B2 (en) * 1991-03-18 1996-05-09 Scripps Research Institute, The Oligosaccharide enzyme substrates and inhibitors: methods and compositions
ATE234092T1 (de) * 1995-09-08 2003-03-15 Novo Nordisk As 2-alkylpyrrolidine
US5770407A (en) * 1996-12-10 1998-06-23 The Scripps Research Institute Process for preparing nucleotide inhibitors of glycosyltransferases

Also Published As

Publication number Publication date
DE60037113T2 (de) 2008-09-18
DE60037113D1 (de) 2007-12-27
EP1185269B1 (de) 2007-11-14
EP1185269A4 (de) 2004-12-01
EP1185269A1 (de) 2002-03-13
WO2001068095A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
WO2001038532A3 (en) Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
GB2386224A (en) Global electronic trading system
NO20005224D0 (no) BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse
WO2005023824A3 (en) Methods for inhibiting tumor cell proliferation
WO2005028443A3 (en) Protein tyrosine kinase enzyme inhibitors
TW200732349A (en) Anti-OX40L antibodies and methods using same
DK1409459T3 (da) ECL mærker, som har forbedrede, non-specifikke bindingsegenskaber, fremgangsmåder til anvendelse deraf, og kits indeholdende samme.
RS20060320A (en) Substituted indazole-o-glucosides
DK1311269T3 (da) Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem
WO2005060377A3 (en) Modulation of immunostimulatory properties by small oligonucleotide-based compounds
TW200620490A (en) Method of forming a thin film component
DE60124759D1 (en) Dna methyl transferase inhibitoren
AU2001268449A1 (en) Toxicity typing using liver stem cells
WO2003048301A3 (en) Anti-hla-dr antibodies and the methods of using thereof
MX2007010332A (es) Metodos y composiciones para promover adhesion o migracion de celula endotelial.
GB2377295A (en) Conversational dealing system
TW200632950A (en) Method to form a thin film resistor
AU2003290592A1 (en) Antitumor benzoylsulfonamides
TW200630348A (en) Tadalafil crystal forms and processes for preparing them
IL138688A0 (en) Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
ATE468408T1 (de) Selektive elution von immobilisierten multiplexierten primerverlängerungsprodukten
IL139852A0 (en) Monoclonal antibodies directed against the g3bp protein, and uses
ATE378421T1 (de) Glycosyltransferase inhibitoren
NO20033921L (no) Inhibitor av monoaminopptak
DE60114567D1 (de) Selektive acylierung von a82846-glycopeptid-analoge

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties